Analytical Data
-
基因名
AGPAT7
- Application
-
别名
LPCAT4; AGPAT7; AYTL3; LPEAT2; Lysophospholipid acyltransferase LPCAT4
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q643R3
-
表达区间
1-524aa
-
氨基酸序列
MSQGSPGDWAPLDPTPGPPASPNPFVHELHLSRLQRVKFCLLGALLAPIRVLLAFIVLFL LWPFAWLQVAGLSEEQLQEPITGWRKTVCHNGVLGLSRLLFFLLGFLRIRVRGQRASRLQ APVLVAAPHSTFFDPIVLLPCDLPKVVSRAENLSVPVIGALLRFNQAILVSRHDPASRRR VVEEVRRRATSGGKWPQVLFFPEGTCSNKKALLKFKPGAFIAGVPVQPVLIRYPNSLDTT SWAWRGPGVLKVLWLTASQPCSIVDVEFLPVYHPSPEESRDPTLYANNVQRVMAQALGIP ATECEFVGSLPVIVVGRLKVALEPQLWELGKVLRKAGLSAGYVDAGAEPGRSRMISQEEF ARQLQLSDPQTVAGAFGYFQQDTKGLVDFRDVALALAALDGGRSLEELTRLAFELFAEEQ AEGPNRLLYKDGFSTILHLLLGSPHPAATALHAELCQAGSSQGLSLCQFQNFSLHDPLYG KLFSTYLRPPHTSRGTSQTPNASSPGNPTALANGTVQAPKQKGD
-
分子量
83.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
AGPAT7 (1-Acylglycerol-3-phosphate O-acyltransferase 7) is a member of the acylglycerol phosphate acyltransferase family, which plays a significant role in lipid metabolism. This enzyme is involved in the regulation of glycerolipid synthesis, contributing to the generation of phosphatidic acid, a key intermediate in lipid biosynthesis and signaling pathways. Research into AGPAT7 has gained momentum due to its potential implications in various metabolic disorders, including obesity, diabetes, and cardiovascular diseases. Alterations in AGPAT7 expression and activity have been linked to insulin resistance and lipid accumulation in adipose tissues. By investigating the structure and function of recombinant AGPAT7, researchers aim to elucidate its biochemical mechanisms, understand its role in cellular lipid homeostasis, and identify potential therapeutic targets for metabolic diseases. Additionally, AGPAT7's involvement in cellular processes such as inflammation and cell proliferation underlines its importance beyond traditional lipid biology, making it a promising candidate for future studies in both basic and translational research. Understanding AGPAT7's functional properties through recombinant technology will aid in the development of novel strategies for combating metabolic disorders and contribute to advancing the field of lipid research.
